10 20 30 40 50 60 70 80 1F6Y - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER TRANSFERASE 23-JUN-00 1F6Y
TITLE MAD CRYSTAL STRUCTURE ANALYSIS OF METHYLTETRAHYDROFOLATE: TITLE 2 CORRINOID/IRON-SULFUR PROTEIN METHYLTRANSFERASE (METR)
COMPND MOL_ID: 1; COMPND 2 MOLECULE: 5-METHYLTETRAHYDROFOLATE CORRINOID/IRON SULFUR PROTEIN COMPND 3 METHYLTRANSFERASE; COMPND 4 CHAIN: A, B; COMPND 5 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MOORELLA THERMOACETICA; SOURCE 3 ORGANISM_TAXID: 264732; SOURCE 4 STRAIN: ATCC 39073; SOURCE 5 CELLULAR_LOCATION: CYTOPLASMIC; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET3A
KEYWDS CARBON DIOXIDE FIXATION, COBALAMIN, METHYLTATRAHYDROFOLATE, KEYWDS 2 METHYLTRANSFERASE, ONE-CARBON METABOLISM, TIM BARREL, HOMODIMER, KEYWDS 3 TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR T.I.DOUKOV,J.SERAVALLI,J.J.STEZOWSKI,S.W.RAGSDALE
REVDAT 4 13-JUL-11 1F6Y 1 VERSN REVDAT 3 24-FEB-09 1F6Y 1 VERSN REVDAT 2 01-APR-03 1F6Y 1 JRNL REVDAT 1 31-AUG-00 1F6Y 0
JRNL AUTH T.DOUKOV,J.SERAVALLI,J.J.STEZOWSKI,S.W.RAGSDALE JRNL TITL CRYSTAL STRUCTURE OF A METHYLTETRAHYDROFOLATE- AND JRNL TITL 2 CORRINOID-DEPENDENT METHYLTRANSFERASE. JRNL REF STRUCTURE FOLD.DES. V. 8 817 2000 JRNL REFN ISSN 0969-2126 JRNL PMID 10997901 JRNL DOI 10.1016/S0969-2126(00)00172-6
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH T.I.DOUKOV,S.ZHAO,C.R.ROSS II,D.L.ROBERTS,KIM. J.J., REMARK 1 AUTH 2 S.W.RAGSDALE,J.J.STEZOWSKI REMARK 1 TITL PRELIMINARY X-RAY CRYSTALLOGRAPHIC STUDY OF REMARK 1 TITL 2 METHYLTETRAHYDROFOLATE: CORRINOID/IRON-SULFUR PROTEIN REMARK 1 TITL 3 METHYLTRANSFERASE FROM CLOSTRIDIUM THERMOACETICUM REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 51 1092 1995 REMARK 1 REFN ISSN 0907-4449 REMARK 1 DOI 10.1107/S0907444995005403 REMARK 1 REFERENCE 2 REMARK 1 AUTH D.L.ROBERTS,S.ZHAO,T.DOUKOV,S.W.RAGSDALE REMARK 1 TITL THE REDUCTIVE ACETYL COENZYME A PATHWAY: SEQUENCE AND REMARK 1 TITL 2 HETEROLOGOUS EXPRESSION OF ACTIVE REMARK 1 TITL 3 METHYLTETRAHYDROFOLATE:CORRINOID/IRON-SULFUR PROTEIN REMARK 1 TITL 4 METHYLTRANSFERASE FROM CLOSTRIDIUM THERMOACETICUM REMARK 1 REF J.BACTERIOL. V. 176 6127 1994 REMARK 1 REFN ISSN 0021-9193 REMARK 1 REFERENCE 3 REMARK 1 AUTH J.SERAVALLI,R.K.SHOEMAKER,M.L.SUDBECK,S.W.RAGSDALE REMARK 1 TITL BINDING OF (6R,S)-METHYLTETRAHYDROFOLATE TO REMARK 1 TITL 2 METHYLTRANSFERASE FROM CLOSTRIDIUM THERMOACETICUM: ROLE OF REMARK 1 TITL 3 PROTONATION OF METHYLTETRAHYDROFOLATE IN THE MECHANISM OF REMARK 1 TITL 4 METHYL TRANSFER REMARK 1 REF BIOCHEMISTRY V. 38 5736 1999 REMARK 1 REFN ISSN 0006-2960 REMARK 1 DOI 10.1021/BI9824745 REMARK 1 REFERENCE 4 REMARK 1 AUTH J.SERAVALLI,S.ZHAO,S.W.RAGSDALE REMARK 1 TITL MECHANISM OF TRANSFER OF THE METHYL GROUP FROM REMARK 1 TITL 2 (6S)-METHYLTETRAHYDROFOLATE TO THE CORRINOID/IRON-SULFUR REMARK 1 TITL 3 PROTEIN CATALYZED BY THE METHYLTRANSFERASE FROM CLOSTRIDIUM REMARK 1 TITL 4 THERMOACETICUM: A KEY STEP IN THE WOOD-LJUNGDAHL PATHWAY OF REMARK 1 TITL 5 ACETYL-COA SYNTHESIS REMARK 1 REF BIOCHEMISTRY V. 38 5728 1999 REMARK 1 REFN ISSN 0006-2960 REMARK 1 DOI 10.1021/BI982473C
REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 7.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 81.8 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : THIN SLICED (SHELX97) REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.209 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.206 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 291 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 34455 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.197 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.194 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 254 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 2409 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3940 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 185 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 4125.00 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 1650 REMARK 3 NUMBER OF RESTRAINTS : 1601 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.000 REMARK 3 ANGLE DISTANCES (A) : 0.000 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.031 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.000 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.010 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.000 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.000 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.080 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1F6Y COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-JUN-00. REMARK 100 THE RCSB ID CODE IS RCSB011319.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-JUL-97 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : R-AXIS REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28189 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 7.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 81.8 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.04800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.25 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.29400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: AB INITIO REMARK 200 SOFTWARE USED: SHELXS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.91 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 9-15% PEGMME 5000, 20% GLYCEROL, 50 MM REMARK 280 HEPES PH 7.5, 20-50 MM CACL2, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.50000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.69250 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.70600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 57.69250 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.50000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.70600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2800 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20280 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -24.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 48 REMARK 465 ALA A 49 REMARK 465 VAL A 50 REMARK 465 GLN A 51 REMARK 465 PRO B 48 REMARK 465 ALA B 49 REMARK 465 VAL B 50 REMARK 465 GLN B 51
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 99 -162.28 -107.42 REMARK 500 ASN A 125 -151.15 -108.68 REMARK 500 LEU A 162 84.71 70.66 REMARK 500 ALA A 169 49.73 -140.84 REMARK 500 ASN B 99 -164.59 -106.97 REMARK 500 LEU B 162 90.53 66.80 REMARK 500 ALA B 228 -169.89 -161.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 TYR A 251 CYS A 252 149.07 REMARK 500 REMARK 500 REMARK: NULL
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AD4 RELATED DB: PDB REMARK 900 DIHYDROPTEROATE SYNTHETASE; CHAIN: A, B; SYNONYM: DHPS; EC: REMARK 900 2.5.1.15 HET: HOH, K, MN, PTP S. AUREUS REMARK 900 RELATED ID: 1AD1 RELATED DB: PDB REMARK 900 DIHYDROPTEROATE SYNTHETASE; CHAIN: A, B; SYNONYM: DHPS; EC: REMARK 900 2.5.1.15; OTHER_DETAILS: APO FORM, S. AUREUS REMARK 900 RELATED ID: 1AJ0 RELATED DB: PDB REMARK 900 DIHYDROPTEROATE SYNTHASE; CHAIN: NULL; SYNONYM: DHPS; EC: REMARK 900 2.5.1.15; BIOLOGICAL_UNIT: HOMODIMER HET: HOH, PH2, SAN, REMARK 900 SO4, E. COLI REMARK 900 RELATED ID: 1AJ2 RELATED DB: PDB REMARK 900 DIHYDROPTEROATE SYNTHASE; CHAIN: NULL; SYNONYM: DHPS; EC: REMARK 900 2.5.1.15; BIOLOGICAL_UNIT: HOMODIMER, E. COLI REMARK 900 RELATED ID: 1AJZ RELATED DB: PDB REMARK 900 DIHYDROPTEROATE SYNTHASE; CHAIN: NULL; SYNONYM: DHPS; EC: REMARK 900 2.5.1.15; BIOLOGICAL_UNIT: HOMODIMER, E. COLI
DBREF 1F6Y A 1 262 UNP Q46389 Q46389_MOOTH 1 262 DBREF 1F6Y B 1 262 UNP Q46389 Q46389_MOOTH 1 262
SEQRES 1 A 262 MET LEU ILE ILE GLY GLU ARG ILE ASN GLY MET PHE GLY SEQRES 2 A 262 ASP ILE LYS ARG ALA ILE GLN GLU ARG ASP PRO ALA PRO SEQRES 3 A 262 VAL GLN GLU TRP ALA ARG ARG GLN GLU GLU GLY GLY ALA SEQRES 4 A 262 ARG ALA LEU ASP LEU ASN VAL GLY PRO ALA VAL GLN ASP SEQRES 5 A 262 LYS VAL SER ALA MET GLU TRP LEU VAL GLU VAL THR GLN SEQRES 6 A 262 GLU VAL SER ASN LEU THR LEU CYS LEU ASP SER THR ASN SEQRES 7 A 262 ILE LYS ALA ILE GLU ALA GLY LEU LYS LYS CYS LYS ASN SEQRES 8 A 262 ARG ALA MET ILE ASN SER THR ASN ALA GLU ARG GLU LYS SEQRES 9 A 262 VAL GLU LYS LEU PHE PRO LEU ALA VAL GLU HIS GLY ALA SEQRES 10 A 262 ALA LEU ILE GLY LEU THR MET ASN LYS THR GLY ILE PRO SEQRES 11 A 262 LYS ASP SER ASP THR ARG LEU ALA PHE ALA MET GLU LEU SEQRES 12 A 262 VAL ALA ALA ALA ASP GLU PHE GLY LEU PRO MET GLU ASP SEQRES 13 A 262 LEU TYR ILE ASP PRO LEU ILE LEU PRO ALA ASN VAL ALA SEQRES 14 A 262 GLN ASP HIS ALA PRO GLU VAL LEU LYS THR LEU GLN GLN SEQRES 15 A 262 ILE LYS MET LEU ALA ASP PRO ALA PRO LYS THR VAL LEU SEQRES 16 A 262 GLY LEU SER ASN VAL SER GLN ASN CYS GLN ASN ARG PRO SEQRES 17 A 262 LEU ILE ASN ARG THR PHE LEU ALA MET ALA MET ALA CYS SEQRES 18 A 262 GLY LEU MET SER ALA ILE ALA ASP ALA CYS ASP GLU ALA SEQRES 19 A 262 LEU ILE GLU THR ALA ALA THR ALA GLU ILE LEU LEU ASN SEQRES 20 A 262 GLN THR VAL TYR CYS ASP SER PHE VAL LYS MET PHE LYS SEQRES 21 A 262 THR ARG SEQRES 1 B 262 MET LEU ILE ILE GLY GLU ARG ILE ASN GLY MET PHE GLY SEQRES 2 B 262 ASP ILE LYS ARG ALA ILE GLN GLU ARG ASP PRO ALA PRO SEQRES 3 B 262 VAL GLN GLU TRP ALA ARG ARG GLN GLU GLU GLY GLY ALA SEQRES 4 B 262 ARG ALA LEU ASP LEU ASN VAL GLY PRO ALA VAL GLN ASP SEQRES 5 B 262 LYS VAL SER ALA MET GLU TRP LEU VAL GLU VAL THR GLN SEQRES 6 B 262 GLU VAL SER ASN LEU THR LEU CYS LEU ASP SER THR ASN SEQRES 7 B 262 ILE LYS ALA ILE GLU ALA GLY LEU LYS LYS CYS LYS ASN SEQRES 8 B 262 ARG ALA MET ILE ASN SER THR ASN ALA GLU ARG GLU LYS SEQRES 9 B 262 VAL GLU LYS LEU PHE PRO LEU ALA VAL GLU HIS GLY ALA SEQRES 10 B 262 ALA LEU ILE GLY LEU THR MET ASN LYS THR GLY ILE PRO SEQRES 11 B 262 LYS ASP SER ASP THR ARG LEU ALA PHE ALA MET GLU LEU SEQRES 12 B 262 VAL ALA ALA ALA ASP GLU PHE GLY LEU PRO MET GLU ASP SEQRES 13 B 262 LEU TYR ILE ASP PRO LEU ILE LEU PRO ALA ASN VAL ALA SEQRES 14 B 262 GLN ASP HIS ALA PRO GLU VAL LEU LYS THR LEU GLN GLN SEQRES 15 B 262 ILE LYS MET LEU ALA ASP PRO ALA PRO LYS THR VAL LEU SEQRES 16 B 262 GLY LEU SER ASN VAL SER GLN ASN CYS GLN ASN ARG PRO SEQRES 17 B 262 LEU ILE ASN ARG THR PHE LEU ALA MET ALA MET ALA CYS SEQRES 18 B 262 GLY LEU MET SER ALA ILE ALA ASP ALA CYS ASP GLU ALA SEQRES 19 B 262 LEU ILE GLU THR ALA ALA THR ALA GLU ILE LEU LEU ASN SEQRES 20 B 262 GLN THR VAL TYR CYS ASP SER PHE VAL LYS MET PHE LYS SEQRES 21 B 262 THR ARG
FORMUL 3 HOH *185(H2 O)
HELIX 1 1 PHE A 12 ARG A 22 1 11 HELIX 2 2 ASP A 23 GLY A 38 1 16 HELIX 3 3 ASP A 52 GLU A 66 1 15 HELIX 4 4 ASN A 78 CYS A 89 1 12 HELIX 5 5 GLU A 101 HIS A 115 1 15 HELIX 6 6 ASP A 132 GLY A 151 1 20 HELIX 7 7 PRO A 153 GLU A 155 5 3 HELIX 8 8 ASP A 171 MET A 185 1 15 HELIX 9 9 SER A 198 GLN A 202 5 5 HELIX 10 10 ASN A 206 CYS A 221 1 16 HELIX 11 11 ASP A 232 LEU A 246 1 15 HELIX 12 12 SER A 254 ARG A 262 1 9 HELIX 13 13 PHE B 12 GLU B 21 1 10 HELIX 14 14 PRO B 24 GLY B 38 1 15 HELIX 15 15 ASP B 52 GLU B 66 1 15 HELIX 16 16 ASN B 78 LYS B 87 1 10 HELIX 17 17 GLU B 101 HIS B 115 1 15 HELIX 18 18 ASP B 132 PHE B 150 1 19 HELIX 19 19 PRO B 153 GLU B 155 5 3 HELIX 20 20 ASP B 171 LYS B 184 1 14 HELIX 21 21 GLY B 196 GLN B 202 5 7 HELIX 22 22 ASN B 206 CYS B 221 1 16 HELIX 23 23 ASP B 232 LEU B 246 1 15 HELIX 24 24 SER B 254 ARG B 262 1 9
SHEET 1 A 9 LEU A 2 GLY A 5 0 SHEET 2 A 9 ALA A 41 LEU A 44 1 O ALA A 41 N GLY A 5 SHEET 3 A 9 THR A 71 ASP A 75 1 O THR A 71 N LEU A 42 SHEET 4 A 9 ALA A 93 THR A 98 1 N MET A 94 O LEU A 72 SHEET 5 A 9 ALA A 118 LEU A 122 1 N ALA A 118 O ALA A 93 SHEET 6 A 9 LEU A 157 ASP A 160 1 N TYR A 158 O LEU A 119 SHEET 7 A 9 LYS A 192 GLY A 196 1 O LYS A 192 N ILE A 159 SHEET 8 A 9 SER A 225 ALA A 228 1 N SER A 225 O THR A 193 SHEET 9 A 9 LEU A 2 GLY A 5 1 O LEU A 2 N ALA A 226 SHEET 1 B 9 LEU B 2 GLY B 5 0 SHEET 2 B 9 ALA B 41 ASN B 45 1 O ALA B 41 N GLY B 5 SHEET 3 B 9 THR B 71 ASP B 75 1 O THR B 71 N LEU B 42 SHEET 4 B 9 ALA B 93 THR B 98 1 N MET B 94 O LEU B 72 SHEET 5 B 9 ALA B 118 LEU B 122 1 O ALA B 118 N ILE B 95 SHEET 6 B 9 LEU B 157 ASP B 160 1 N TYR B 158 O LEU B 119 SHEET 7 B 9 LYS B 192 LEU B 195 1 O LYS B 192 N ILE B 159 SHEET 8 B 9 SER B 225 ALA B 228 1 N SER B 225 O THR B 193 SHEET 9 B 9 LEU B 2 GLY B 5 1 O LEU B 2 N ALA B 226
CISPEP 1 ASN A 96 SER A 97 0 7.29 CISPEP 2 ASP A 188 PRO A 189 0 -7.46 CISPEP 3 ASN B 96 SER B 97 0 7.56 CISPEP 4 ASP B 188 PRO B 189 0 3.70
CRYST1 65.000 89.412 115.385 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.015385 0.000000 0.000000 0.00000
SCALE2 0.000000 0.011184 0.000000 0.00000
SCALE3 0.000000 0.000000 0.008667 0.00000